C0936012||Analysis
C0011847||diabetes
C1112209||intra-abdominal infection
C0042029||urinary tract infection
C0282461||phase 3 trials
C3656593||ceftolozane/tazobactam
C0011849||Diabetes mellitus
C0020456||hyperglycemia
C2748958||increased susceptibility to bacterial infections
C0220825||post hoc evaluation
C0087111||treatment
C1112209||intra-abdominal infections
C1112209||complicated intra-abdominal infections
C0042029||urinary tract infections
C0042029||complicated urinary tract infections
C0220825||evaluate
C0011847||diabetes
C0087111||treated
C3656593||ceftolozane/tazobactam
C3656593||Ceftolozane/tazobactam
C0279516||antibacterial
C0018150||Gram-negative pathogens
C0087111||treatment
C1112209||complicated intra-abdominal infections
C0025872||metronidazole
C0042029||complicated urinary tract infections
C0034186||pyelonephritis
C0282461||phase 3 ASPECT
C2603343||studies
C0011847||diabetes
C0220825||evaluate
C3656593||ceftolozane/tazobactam
C0011847||diabetes
C0001792||older
C0011847||diabetes
C1565489||renal impairment
C0489438||APACHE II scores
C0011847||diabetes
C1112209||complicated intra-abdominal infections
C0042029||complicated urinary tract infections
C1112209||complicated intra-abdominal infections
C0042029||complicated urinary tract infections
C3161471||study treatments
C0441994||lower
C0011847||diabetes
C1112209||complicated intra-abdominal infections
C0042029||complicated urinary tract infections
C3656593||ceftolozane/tazobactam
C0087111||treatment
C0700287||reported
C3656593||ceftolozane/tazobactam
C0282386||levofloxacin
C0011847||diabetes
C0042029||complicated urinary tract infections
C0877248||adverse events
C0011847||diabetes
C0087111||treatment
C0877248||adverse events
C0936012||hoc analysis
C0011847||diabetes
C0001792||older
C0011847||diabetes
C0441994||lower
C0877248||adverse events
C0011847||diabetes
C3656593||Ceftolozane/tazobactam
C0441994||at least
C0087111||treating
C0042029||complicated urinary tract infections
C1112209||complicated intra-abdominal infections
C1257890||population
C1112209||complicated intra-abdominal infections
C0042029||complicated urinary tract infections